All nine members of the committee unanimously voted to recommend Moderna's new mRNA influenza vaccine for adults 50 and over.
A key FDA committee has unanimously recommended Moderna's new mRNA influenza vaccine for adults aged 50 and over. All nine committee members voted in favor, marking the first vaccine recommendation by this committee since 2023. This positive development could lead to broader…
Market Samachar is a news aggregator. This article was originally published by NPR. Tap the button above to read the full story on their site.